Skip to main content
 This program is not active.
On Demand

Vaccine Development During the COVID-19 Pandemic


Total Credits: .75 including .75 AMA PRA Category 1 Credit(s)™

Average Rating:
   1
State Associations:
AOMA - Arizona
Faculty:
Peter Marks, MD, PhD
Duration:
00:43
Expiration:
Access for 60 day(s) after purchase.


Description

Vaccine Development During the COVID-19 Pandemic
Peter Marks, MD, PhD

  • Exam the considerations used to expedite vaccine development during the pandemic
  • Differentiate the characteristics of available vaccines
  • Outline issues surrounding vaccine deployment

Dr. Marks has no disclosures. 

Accreditation
The Arizona Osteopathic Medical Association (AOMA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The AOMA designates this live activity for a maximum of .75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

GRIEVANCE POLICY
All grievances should be forwarded to the AOMA Executive Director, Matt Helms by calling the AOMA Office at 602-266-6699 or by mail to AOMA, 3901 W. Peoria Ave., Suite C102-158, Phoenix, AZ 85029 or by email info@azosteo.org.

 

Handouts

Faculty

Peter Marks, MD, PhD's Profile

Peter Marks, MD, PhD Related Seminars and Products


Peter Marks received his graduate degree in cell and molecular biology and his medical degree at New York University and completed Internal Medicine residency and Hematology/Medical Oncology training at Brigham and Women’s Hospital in Boston. He has worked in academic settings teaching and caring for patients and in industry on drug development.  He joined the FDA in 2012 as Deputy Center Director for CBER and became Center Director in January 2016.

Dr. Marks has no disclosures.


Reviews

5
4
3
2
1

Overall:      4

Total Reviews: 1